Modified Bentall operation with a novel biologic valved conduit.

Area of Science:

• Cardiovascular Surgery
• Biomedical Engineering
• Medical Devices

Background:

• The optimal valved conduit for modified Bentall operations is not yet established.
• A novel valved conduit combining the 3f Aortic Bioprosthesis and Vascutek Gelweave Valsalva Aortic Root Graft was developed.

Purpose of the Study:

• To evaluate the hemodynamics and early clinical results of this newly developed valved conduit.
• To assess the feasibility and safety of the new conduit in patients undergoing modified Bentall operations.

Main Methods:

• A retrospective review of 20 patients who underwent a modified Bentall operation using the new valved conduit between December 2008 and April 2009.
• Analysis of patient records, including indications for surgery, previous cardiac history, and concomitant procedures.
• Assessment of perioperative outcomes, including mortality and hemodynamic performance via transesophageal echocardiogram.

Main Results:

• Indications included aortic root aneurysm (14), acute type A dissection (5), and homograft deterioration (1).
• Four patients had prior cardiac surgery, and 8 required concurrent procedures.
• No perioperative deaths occurred, with an average mean pressure gradient of 4.0 +/- 1.7 mm Hg across the bioprosthesis.

Conclusions:

• Initial experience with the new valved conduit in modified Bentall operations yielded favorable early results.
• The developed valved conduit shows promise for aortic root replacement.
• Longer follow-up and a larger patient cohort are necessary to further validate these findings.